Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9593077 Ionizable cationic lipid for RNA delivery

Patent 9593077 was granted and assigned to Arcturus Therapeutics on March, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Arcturus Therapeutics

Current Assignee

Arcturus Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

95930770

Patent Inventor Names

Joseph E. Payne0

Padmanabh Chivukula0

Date of Patent

March 14, 2017

Patent Application Number

145461050

Date Filed

November 18, 2014

Patent Citations Received

‌

US Patent 12018289 Vaccines based on mutant CALR and JAK2 and their uses

‌

US Patent 12083224 Lipid particles for nucleic acid delivery

‌

US Patent 12070509 Nucleic acids and methods of treatment for cystic fibrosis

Patent Primary Examiner

‌

Paul A. Zucker

Patent abstract

What is described is a compound of formula (1)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9593077 Ionizable cationic lipid for RNA delivery

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API